Paul A. Wagner is of Forte Biosciences, Inc.. Currently has a direct ownership of 80,940 shares of FBRX, which is worth approximately $1.01 Million. The most recent transaction as insider was on Jul 31, 2023, when has been sold 247,524 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $249,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.9K
1.44% 3M change
95.76% 12M change
Total Value Held $1.01 Million

Paul A. Wagner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2023
BUY
Grant, award, or other acquisition
$249,999 $1.01 p/Share
247,524 Added 12.87%
1,675,574 Common Stock
Jul 01 2023
SELL
Payment of exercise price or tax liability
$2,551 $1.04 p/Share
2,453 Reduced 0.17%
1,428,050 Common Stock
Jul 01 2023
BUY
Exercise of conversion of derivative security
-
31,250 Added 2.14%
1,430,503 Common Stock
Apr 01 2023
SELL
Payment of exercise price or tax liability
$11,156 $1.01 p/Share
11,046 Reduced 0.78%
1,399,253 Common Stock
Apr 01 2023
BUY
Exercise of conversion of derivative security
-
31,250 Added 2.17%
1,410,299 Common Stock
Dec 16 2022
BUY
Open market or private purchase
$47,105 $1.07 p/Share
44,024 Added 3.09%
1,379,049 Common Stock
Dec 15 2022
BUY
Open market or private purchase
$57,655 $1.03 p/Share
55,976 Added 4.02%
1,335,025 Common Stock
Sep 07 2021
SELL
Open market or private sale
$4,350,000 $4.35 p/Share
1,000,000 Reduced 43.88%
1,279,049 Common Stock
PAW

Paul A. Wagner

Torrance, CA

Track Institutional and Insider Activities on FBRX

Follow Forte Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FBRX shares.

Notify only if
Any

Insider Trading

Get notified when an Forte Biosciences, Inc. insider buys or sells FBRX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Forte Biosciences, Inc.

Track Activities on FBRX